The Effect of Intravitreal Azithromycin on the Albino Newborn Rabbit Retina

被引:3
作者
Cam, Duygu [1 ]
Saatci, Ali Osman [2 ]
Micili, Serap Cilaker [3 ]
Ergur, Bekir Ugur [3 ]
Karabag, Revan Yildirim [4 ]
Durak, Ismet [2 ]
Berk, Ayse Tulin [2 ]
机构
[1] State Hosp, Dept Ophthalmol, Tunceli, Turkey
[2] Dokuz Eylul Univ, Dept Ophthalmol, Izmir, Turkey
[3] Dokuz Eylul Univ, Dept Histol & Embryol, Izmir, Turkey
[4] State Hosp, Dept Ophthalmol, Manisa, Turkey
关键词
Azithromycin; apoptic cell death; bacteriostatic agent; retina;
D O I
10.2174/1874364101610010012
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the effect of intravitreal azithromycin on the retina in a newborn rabbit model. Methods: Twelve, two-week old New Zealand albino rabbits were divided into two groups (six in each). The right eyes of six rabbits received 0.75 mg (0.05 mL) azithromycin and the right eyes of the remaining six rabbits 1.5 mg (0.1 mL) azithromycin intravitreally. Left eyes were served as the control and received the same volume of saline. All eyes were enucleated at the third postinjection week. Retinal histology was examined by light microscopy. Apoptosis of the retinal cells was further evaluated by immunohistochemical staining for caspase-3 and in situ terminal deoxynucleotidyl transferase-mediated biotin-deoxyuridine triphosphate nickend labeling (TUNEL) of DNA fragments. Results: Light microscopy demonstrated no retinal abnormalities in all eyes. However, retinal nuclear DNA fragmentation was evident in both study groups (33.6% with 1.5 mg and 21.4% with 0.75 mg azithromycin) with the TUNEL method. TUNEL staining ratio was statistically higher only in the second group treated with 1.5 mg azithromycin when compared to the control group (p=0.01 Mann Whitney U test). The ratio of caspase-3 positive cells in the two study groups was 21.5% and 20.2%, respectively. Caspase-3 staining ratio was statistically higher in both study groups when compared to the control eyes (p=0.00, p=0.00 respectively). The difference of TUNEL staining ratio between the two study groups was statistically significant (p=0.028), but there were no statistically significant differences in the two study groups by caspase-3 staining (p=0.247). Conclusion: In newborn rabbits, intravitreal azithromycin injection resulted in an apoptotic activity in the photoreceptor, bipolar and ganglion cells. Immunohistochemical analysis suggested that doses of 0.75 mg and 1.5 mg azithromycin, administered intravitreally might be toxic to the newborn rabbit retina.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 16 条
[1]   Ocular Surface Distribution and Pharmacokinetics of a Novel Ophthalmic 1% Azithromycin Formulation [J].
Akpek, Esen Karamursel ;
Vittitow, Jason ;
Verhoeven, Rozemarijn S. ;
Brubaker, Kurt ;
Amar, Thierry ;
Powell, Kendall D. ;
Boyer, Jose L. ;
Crean, Christopher .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (05) :433-439
[2]  
Bell S C, 2005, Chron Respir Dis, V2, P85, DOI 10.1191/1479972305cd066rs
[3]   AZITHROMYCIN UPTAKE AND INTRACELLULAR ACCUMULATION BY TOXOPLASMA GONDII-INFECTED MACROPHAGES [J].
BLAIS, J ;
BEAUCHAMP, D ;
CHAMBERLAND, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (03) :371-382
[4]   Azithromycin for the treatment of cat-scratch disease [J].
Chia, JKS ;
Nakata, MM ;
Lami, JLM ;
Park, SS ;
Ding, JC .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :193-194
[5]   In vitro evaluation of intracellular activity of antibiotics against non-typhoid Salmonella [J].
Chiu, CH ;
Lin, TY ;
Ou, JT .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 12 (01) :47-52
[6]   3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children [J].
Cochereau, Isabelle ;
Meddeb-Ouertani, Amel ;
Khairallah, Moncef ;
Amraoui, Abdelouahed ;
Zaghloul, Khalid ;
Pop, Mihai ;
Delval, Laurent ;
Pouliquen, Pascale ;
Tandon, Radhika ;
Garg, Prashant ;
Goldschmidt, Pablo ;
Bourcier, Tristan .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (04) :465-469
[7]   Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients [J].
Espiritu, Cesar Ramon G. ;
Caparas, Victor L. ;
Bolinao, Joanne G. .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (01) :63-68
[8]   Intravitreal moxifloxacin: Retinal safety study with electroretinography and histopathology in animal models [J].
Gao, H ;
Pennesi, ME ;
Qiao, XX ;
Iyer, MN ;
Wu, SM ;
Holz, ER ;
Mieler, WF .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (04) :1606-1611
[9]   In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment [J].
Kernt, Marcus ;
Neubauer, Aljoscha Steffen ;
Ulbig, Michael W. ;
Karnpik, Anselm ;
Welge-Luessen, Ulrich .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2008, 34 (03) :480-488
[10]   Intracameral Vigamox® (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model [J].
Kowalski, RP ;
Romanowski, EG ;
Mah, FS ;
Yates, KA ;
Gordon, YJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (03) :497-504